Advanced Proteome Therapeutics Corporation (TSE:APC.H)
TSXV:APC.H
Holding TSE:APC.H?
Track your performance easily

Advanced Proteome Therapeutics (APC.H) Stock Price & Analysis

0 Followers

APC.H Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

37.48%0.00%0.00%62.52%
37.48%
Insiders
0.00% Other Institutional Investors
62.52% Public Companies and
Individual Investors

APC.H FAQ

What was Advanced Proteome Therapeutics Corporation’s price range in the past 12 months?
Advanced Proteome Therapeutics Corporation lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
    What is Advanced Proteome Therapeutics Corporation’s market cap?
    Currently, no data Available
    When is Advanced Proteome Therapeutics Corporation’s upcoming earnings report date?
    Advanced Proteome Therapeutics Corporation’s upcoming earnings report date is Dec 19, 2024 which is in 90 days.
      How were Advanced Proteome Therapeutics Corporation’s earnings last quarter?
      Currently, no data Available
      Is Advanced Proteome Therapeutics Corporation overvalued?
      According to Wall Street analysts Advanced Proteome Therapeutics Corporation’s price is currently same. Get more investment ideas with TipRanks Premium
        Does Advanced Proteome Therapeutics Corporation pay dividends?
        Advanced Proteome Therapeutics Corporation pays a Notavailable dividend of <C$0.01 which represents an annual dividend yield of N/A. See more information on Advanced Proteome Therapeutics Corporation dividends here
          What is Advanced Proteome Therapeutics Corporation’s EPS estimate?
          Advanced Proteome Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Advanced Proteome Therapeutics Corporation have?
          Advanced Proteome Therapeutics Corporation has 41,127,080 shares outstanding.
            What happened to Advanced Proteome Therapeutics Corporation’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Advanced Proteome Therapeutics Corporation?
            Currently, no hedge funds are holding shares in TSE:APC.H
            ---

            Advanced Proteome Therapeutics Stock Smart Score

            Company Description

            Advanced Proteome Therapeutics Corporation

            Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            BriaCell Therapeutics
            Innoveren Scientific
            US Stem Cell
            Premier Biomedical
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis